share_log

Adial Pharmaceuticals Q1 EPS $(2.19) Misses $(0.35) Estimate

Adial Pharmaceuticals Q1 EPS $(2.19) Misses $(0.35) Estimate

Adial Pharmicals第一季度每股收益美元(2.19美元)未达到预期(0.35美元)
Benzinga ·  05/15 08:45

Adial Pharmaceuticals (NASDAQ:ADIL) reported quarterly losses of $(2.19) per share which missed the analyst consensus estimate of $(0.35) by 525.71 percent. This is a 20.36 percent increase over losses of $(2.75) per share from the same period last year.

Adial Pharmicals(纳斯达克股票代码:ADIL)公布的季度亏损为每股2.19美元,比分析师普遍预期的0.35美元(0.35美元)低525.71%。这比去年同期每股亏损2.75美元(2.75美元)增长了20.36%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发